首页>
外国专利>
BIO-MARKER FOR PREDICTING AIRWAY RESPONSIVENESS OF ICS IN THE ASTHMATIC PATIENTS INCLUDING TAAR6 POLYMORPHISMS RS7772821 AND THE DIAGNOSING KIT INCLUDING THE SAME
BIO-MARKER FOR PREDICTING AIRWAY RESPONSIVENESS OF ICS IN THE ASTHMATIC PATIENTS INCLUDING TAAR6 POLYMORPHISMS RS7772821 AND THE DIAGNOSING KIT INCLUDING THE SAME
The present invention relates to biomarkers for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients with rs7772821TG polynucleotide in a TAAR6 gene and a disgnostic kit including the same and, more specifically, to biomarkers comprising rs7772821TG polynucleotide or complementary polynucleotide thereof in a TAAR6 gene to predict the fact that airway responsiveness is increased when administrating inhaled corticosteroids to asthmatic patients, and to a diagnostic kit including the biomarkers. The present invention provides biomarkers for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients, comprising rs7772821TG polynucleotide or complementary polynucleotide thereof in a TAAR6 gene. In addition, the present invention provides a diagnostic kit for predicting airway responsiveness to inhaled corticosteroids in asthmatic patients, comprising one or more of the biomarkers.
展开▼